or an adequate function of platelets and megakaryocytes, a tight balance between stimulatory and inhibitory signals is required. Inhibitory receptors that carry immunoreceptor tyrosine-based inhibition motifs (ITIMs) in their cytoplasmic tail play an essential role in the regulation of megakaryocyte and platelet reactivity.
F
or an adequate function of platelets and megakaryocytes, a tight balance between stimulatory and inhibitory signals is required. Inhibitory receptors that carry immunoreceptor tyrosine-based inhibition motifs (ITIMs) in their cytoplasmic tail play an essential role in the regulation of megakaryocyte and platelet reactivity. 1, 2 Platelets express at least 5 ITIMcontaining receptors, platelet endothelial cell adhesion molecule-1 (PECAM-1), carcinoembryonic antigen-related cell adhesion molecule-1, carcinoembryonic antigen-related cell adhesion molecule-2, triggering receptor expressed in myeloid cells-like transcript-1, and G6b-B. PECAM-1 is a well-characterized ITIM-containing receptor that has been reported to inhibit signaling via the immunoreceptor tyrosinebased activation motif-containing collagen receptor complex glycoprotein VI (GPVI)-FcRγ-chain and thrombin-mediated platelet activation. 1 Carcinoembryonic antigen-related cell adhesion molecule-1 was shown to have a similar function in platelets to that of PECAM-1. 3 Carcinoembryonic antigenrelated cell adhesion molecule-2 is a novel platelet immunoreceptor that has been shown to act as a negative regulator of platelet GPVI-FcRγ-chain and of the hemi-immunoreceptor tyrosine-based activation motif-containing podoplanin receptor CLEC-2 (C-type lectin-like receptor 2) pathways. 4 In contrast, the platelet-specific ITIM-containing triggering receptor expressed in myeloid cells-like transcript-1 is upregulated on the surface of activated platelets and plays a role in supporting, rather than inhibiting, platelet activation. 5 Unique among ITIM-containing receptors, G6b-B is highly abundant in mature megakaryocytes and platelets and is constitutively phosphorylated and associated with the SH2 domain-containing nontransmembrane protein tyrosine phosphatases Shp1 and Shp2. 6 We recently reported that G6b-B is a major regulator of megakaryocyte/platelet homeostasis and platelet reactivity. 2, 7 Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), also known as CD305, is a collagen receptor that belongs to the inhibitory immunoglobulin-ITIM family. 8 LAIR-1 is expressed widely on hematopoietic cells, including immature megakaryocytes, but is not detectable in platelets. 9 LAIR-1 possesses a single extracellular immunoglobulin variable domain and 2 ITIMs in its cytoplasmic tail that mediate its inhibitory capacity through the interaction with Shp1, Shp2, and C-terminal Src kinase. 10, 11 LAIR-1 binds with higher affinity than GPVI to glycine-proline-hydroxyproline repeat motifs in collagen. 12, 13 Previously, we have shown that coexpression of LAIR-1 with GPVI in transiently transfected DT40 chicken B cells mediates strong inhibition of collagen-mediated activation of an NFAT (nuclear factor of activated T-cells) reporter assay. 14 Several studies have shown that LAIR-1 also functions as an inhibitory receptor on immune cells and is involved in the regulation of hematopoietic cell differentiation. [15] [16] [17] [18] In addition, recent studies report that LAIR-1 is essential for acute myeloid leukemia development. 19, 20 However, the role of LAIR-1 in megakaryocyte development and platelet formation is not known.
In this study, we investigate the role of LAIR-1 in megakaryopoiesis and platelet activation. We show that mice lacking LAIR-1 exhibit a mild thrombocytosis, increased proplatelet formation in vitro, and produce hyperactive platelets. Furthermore, LAIR-1-deficient megakaryocytes exhibit increased reactivity to collagen and increased αIIbβ3 outside-in signaling, despite having normal cell surface levels of the collagen receptors GPVI and the integrin α2β1 and of the fibrinogen integrin αIIbβ3. The increase in reactivity observed in LAIR-1-deficient megakaryocytes is also seen in platelets, suggesting transfer of activation signals from megakaryocytes to platelets.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

LAIR-1 and GPVI Are Inversely Expressed During Megakaryopoiesis In Vitro
We first analyzed the expression of LAIR-1 alongside other major surface glycoproteins during mouse megakaryocyte differentiation by flow cytometry. Bone marrow progenitor cells were isolated from wild-type (WT) mice and cultured in the presence of 20 ng/mL thrombopoietin for 8 days. Cells were harvested every day and receptor surface expression measured by flow cytometry. LAIR-1 was highly expressed on mouse hematopoietic stem cells and its expression decreased during megakaryopoiesis ( Figure 1A and 1B), whereas the opposing relationship was observed for the collagen receptors, GPVI and α2β1. Importantly, GPVI and α2β1 were highly expressed on mouse platelets, but LAIR-1 expression was not detectable by flow cytometry or Western blot ( Figure 1B and Figure 2Ai ). These results demonstrate that GPVI and LAIR-1 are inversely expressed during mouse megakaryopoiesis in vitro as is the case for human megakaryocytes. 9 However, a subset of intermediate megakaryocytes expressed both activatory and inhibitory receptors for collagen. In this population of megakaryocytes, the GPVI-specific agonist convulxin, which does not bind to LAIR-1, 14 stimulated phosphorylation of LAIR-1 ( Figure 1C ).
LAIR-1-Deficient Mice Exhibit Mild Thrombocytosis and Increased Platelet Half-Life
To study the physiological function of LAIR-1, we generated LAIR-1-deficient mice ( Figure I in the online-only Data Supplement). Homozygous LAIR-1 knockout mice (LAIR-1 KO) were born at Mendelian frequencies, were fertile, and survived for >25 weeks with no overt growth or developmental defects. By Western blotting, LAIR-1 was not detectable in immature megakaryocytes from LAIR-1 KO mice or in platelets from WT and LAIR-1 KO mice (Figure 2Ai ). Hematological analysis revealed that LAIR-1 KO mice displayed a mild thrombocytosis (25% increase in platelet count) with unchanged platelet volume (Figure 2Aii -iii). Platelets and megakaryocytes from LAIR-1 KO mice have normal organelles and granule content as assessed by transmission electron microscopy ( Figure 2B and not shown). LAIR-1 KO mice did not exhibit a bleeding diathesis after tail injury ( Figure To investigate whether the thrombocytosis was the result of decreased platelet clearance, platelet half-life was measured in vivo. Interestingly, we found that the half-life of platelets from LAIR-1 KO mice was increased by 17% ( Figure 2C ), thereby accounting for the mild thrombocytosis.
Normal Megakaryocyte Development, But Increased Proplatelet Formation in LAIR-1 KO Mice
We next investigated whether LAIR-1 regulates megakaryocyte differentiation in vitro by analyzing their DNA content during development. The absence of LAIR-1 had no effect on megakaryocyte development as shown by a normal ploidy pattern (Figure 3Ai -ii) and cellular appearance (data not shown). LAIR-1-deficient megakaryocytes exhibited a marked increase in spreading on a fibrinogen-coated surface (Figure 3Bi -ii), despite having normal levels of αIIbβ3 ( branching of proplatelets was also observed (Figure 3Ci-iii) . These results demonstrate that LAIR-1 exhibits a tonic inhibitory effect on megakaryocyte spreading on fibrinogen and on platelet formation. Because LAIR-1 is a collagen receptor, we have also investigated megakaryocyte spreading and proplatelet formation on collagen. We show that LAIR-1-deficient megakaryocytes spread normally on collagen and that neither WT nor LAIR-1 KO megakaryocytes formed proplatelets on collagen ( Figure IV in the online-only Data Supplement and data not shown).
Unchanged Thrombopoietin Signaling, But Increased Reactivity to Collagen in LAIR-1-Deficient Megakaryocytes
Having demonstrated increased spreading and proplatelet formation in LAIR-1 KO megakaryocytes, we investigated the molecular basis of these defects. We focused on thrombopoietin-and integrin-mediated Erk1/2 phosphorylation and Src family kinase (SFK) activation, as we have previously demonstrated that Erk1/2 plays a critical role in primary megakaryocyte differentiation, motility, and proplatelet formation 21 and that SFKs regulate megakaryocyte differentiation and platelet production. 21 Phospho-specific antibodies were used to monitor Erk1/2 and SFK activation. Thrombopoietin-mediated Erk1/2 activation was normal in LAIR-1-deficient megakaryocytes (Figure 4Ai) , consistent with the normal growth and ploidy of these cells (Figure 3Ai -ii). SFK activation, which lies upstream of Erk1/2, was, however, enhanced in resting LAIR-1-deficient megakaryocytes compared with controls (Figure 4Aii ), suggesting that basal SFK activity was increased. Despite the extent of basal SFK activation being increased, SFKs were phosphorylated to the same extent on their activation loop (Tyr-418) by thrombopoietin in control and mutant megakaryocytes (Figure 4Aii ). In addition, basal and integrin αIIbβ3-mediated Erk1/2 and SFK activation were increased in fibrinogen-adhered LAIR-1-deficient megakaryocytes (Figure 4Bi Because LAIR-1 is an inhibitory collagen receptor, we investigated GPVI signaling in LAIR-1-deficient megakaryocytes. Interestingly, we show that phosphorylation of SFK Tyr-418, the tyrosine kinase Syk on its activation loops (Syk Tyr-519/520), and of its downstream target PLCγ2 on Tyr-1217, all of which are indicators of activation, were significantly increased in LAIR-1-deficient resting and convulxin-stimulated megakaryocytes (Figure 4Ci-iii) , despite having a normal surface level of GPVI (Table 1) . However, phosphorylation of Src, Fyn, and Lyn at their C-terminal inhibitory tyrosine residues, Tyr-529, Tyr-530, and Tyr-507, respectively, were unchanged (Figure V in the online-only Data Supplement).
LAIR-1-Deficient Mice Exhibit Increased Platelet Function
Platelet aggregation and ATP secretion were measured to investigate whether the absence of LAIR-1 in megakaryocytes alters platelet function. An increase in response to collagen, which binds to GPVI and α2β1 and to the GPVI-specific agonist collagen-related peptide (CRP), but not to convulxin, was observed in platelets from LAIR-1 KO mice using light transmission aggregometry (Figure 5Ai -iii, Figure 5Bi -iii, and Figure VIAi -ii in the online-only Data Supplement, respectively), despite having normal expression levels of the collagen receptors GPVI and α2β1 ( Table 2 ). The expression levels of integrin αIIbβ3, GPIbα, and of the ITIM-containing receptors G6b-B and PECAM-1 remained unchanged (Table 2) We next investigated platelet spreading on a fibrinogencoated surface because this is an important aspect of platelet function that is dependent on the integrin αIIbβ3 for adhesion and cytoskeletal remodeling. 22 Platelets from LAIR-1 KO mice exhibited an increase in spreading on fibrinogen in comparison with WT platelets (Figure 6Ai-ii) , suggesting that LAIR-1 negatively regulates this process. However, when preactivated with 0.1 U/mL thrombin, platelets from LAIR-1 KO mice spread normally (Figure 6Ai-ii) . Therefore, LAIR-1 is involved in the regulation of αIIbβ3 outside-in signaling but not in the regulation of protease-activated receptor-4 signaling.
Whole-cell lysates prepared from fibrinogen-spread and nonadherent platelets exhibited an increase in phosphorylation of Src Tyr-418 and Syk Tyr-519/520, in platelets from LAIR-1 KO mice (Figure 6Bi-ii) , consistent with the increase in spreading, whereas phosphorylation of Src Tyr-529, Fyn Tyr-530, and Lyn Tyr-507 were unchanged ( Figure VII in the online-only Data Supplement), providing further evidence of a proximal signaling defect. Integrin αIIbβ3 outside-in signaling also regulates clot retraction. To study whether the loss of LAIR-1 alters clot retraction, clot formation was induced in platelet-rich plasma by addition of a high concentration of thrombin (10 U/mL) in the presence of 2 mmol/L Ca 2+ and was monitored over time. No differences were observed, and the excess fluid 
Increased GPVI-Mediated Signaling in Platelets From LAIR-Deficient Mice
The molecular basis of the increase in reactivity to collagen and CRP was investigated by monitoring protein phosphorylation. Western blotting revealed a general increase in tyrosine phosphorylation in response to CRP in platelets from LAIR-1 KO mice (Figure 7Ai However, interestingly, they formed larger aggregates on a collagen matrix under arterial shear and covered a larger surface area ( Figure 7C ). The physiological role of LAIR-1 in arterial thrombosis was also investigated in vivo using 2 distinct assays, namely the laser-and ferric chloride-induced injury models. We found that, in the laser injury model in cremaster arterioles, thrombus formation was unaffected in LAIR-1 KO mice (Figure 7Di -ii and Videos SI and SII in the online-only Data Supplement). However, using the ferric chloride injury model in the carotid artery, we show that the rate and extent of thrombus formation is significantly increased in the LAIR-1 KO mice compared with litter-matched WT mice (Figure 7Ei -iii and Videos SIII and SIV in the online-only Data Supplement). These findings correlate with the increase in platelet reactivity to collagen demonstrated in vitro. Taken together, these findings demonstrate that the lack of inhibition of immunoreceptor tyrosine-based activation motif signaling in LAIR-1-deficient megakaryocytes is transferred to platelets, resulting in enhanced GPVI-mediated signaling through increased SFK activity resulting in greater platelet activation and a predisposition to thrombosis that is dependent on the type of injury and vasculature.
Discussion
In this study, we investigated the role of LAIR-1 in megakaryocyte development and platelet production by generating and characterizing LAIR-1 KO mice. We demonstrate for the first time that LAIR-1 is a negative regulator of platelet production and reactivity to collagen and fibrinogen. Mice lacking LAIR-1 exhibit a 25% increase in platelet counts, a prolonged platelet half-life in vivo, and increased proplatelet formation in vitro. Interestingly, platelets from LAIR-1 KO mice exhibit an enhancement of reactivity to GPVI and αIIbβ3 agonists, despite not expressing LAIR-1 and having normal receptor levels, and formed larger aggregates on a collagen matrix under arterial shear. As a consequence, LAIR-1 KO mice exhibited increased thrombus formation after ferric chloride-induced carotid artery injury, which has been shown to be GPVI-dependent, 23 but not after laser-induced injury of cremaster arterioles, which is tissue factor and thrombindependent. 23 In addition, the composition of the vessel wall and rheological characteristics differ between these models, which likely influences the differences observed. Findings from this study demonstrate that ablation of LAIR-1 in megakaryocytes leads to an increased SFK activity and downstream signaling in response to collagen that is transmitted to platelets, rendering them hyper-reactive specifically to agonists that signal through SFKs, but not through G protein-coupled receptors.
We first examined the expression of collagen receptors (LAIR-1, GPVI, α2β1) and surface marker expression of CD34, GPIbα, and αIIbβ3 at different stages of megakaryocyte maturation. During murine megakaryocyte maturation, the inhibitory collagen receptor LAIR-1 is downregulated, whereas the activating collagen receptor GPVI is upregulated. However, a subset of cells coexpress these collagen receptors with opposite functions, as previously shown during human megakaryopoiesis. 9 These findings raise the question of why LAIR-1 would be expressed at these early stages of megakaryocyte differentiation. One possible explanation is that this could prevent the excessive activation of immature megakaryocytes exposed to surrounding collagens. The main collagen receptors expressed by megakaryocytes are the high affinity integrin α2β1, the low affinity immunoreceptor tyrosine-based activation motif-containing receptor GPVI-FcRγ-chain complex, and LAIR-1, which has the same binding site as GPVI, but with a considerably higher affinity. 12 Deletion of LAIR-1 in mice leads to an increase in the number of circulating platelets compared with litter-matched controls. Despite this, megakaryocyte counts were normal in the spleen and bone marrow of LAIR-1 KO mice and reticulin staining revealed no evidence of tissue damage in the spleen and bone marrow of LAIR-1 KO mice. We show that platelet half-life is increased, thereby accounting for the mild thrombocythemia. Recent studies have highlighted the role of glycan modification on platelet surface proteins mediating platelet clearance. 24, 25 Indeed, life span of circulating platelets is determined by sialic acid loss that triggers platelet removal by the hepatic Ashwell-Morell receptor. 25 Circulating platelets become desialylated as they age, however, in preliminary studies, we did not observe a change in staining for sialic acid in platelets from LAIR-1 KO mice. Platelet survival also Representative blots and densitometry quantification from n=3 to 5 independent experiments/genotype (mean±SEM; *P<0.05). C, Bone marrow-derived megakaryocytes from litter-matched WT and LAIR-1 KO mice were stimulated with 30 µg/mL convulxin for 15 minutes at 37°C. Whole-cell lysates were Western blotted with anti-Src p-Tyr418, anti-Syk p-Tyr519/520, and anti-PLCγ2 p-Tyr1217 antibodies. Membranes were stripped and reblotted with antipan Src, antipan Syk, and antipan PLCγ2 antibodies. Ci, Representative blots and (Cii) densitometry quantification from n=4 independent experiments/genotype (mean±SEM; *P<0.05, **P<0.01). depends on the interplay between prosurvival and proapoptotic signals, 26 and a change in either of these could underlie the increase in platelet life span.
We also found that LAIR-1 KO mice exhibit normal megakaryocyte development as measured by ploidy levels but enhanced proplatelet formation on fibrinogen suggesting that platelet biogenesis is enhanced, providing a further basis for the increase in platelet count. We investigated the molecular mechanism underlying the increased proplatelet formation exhibited by the LAIR-1-deficient megakaryocytes by examining phosphorylation of key signaling proteins downstream of integrin αIIbβ3. We found that Erk1/2 and SFK activation were increased in fibrinogen-adherent LAIR-1-deficient megakaryocytes as is similarly the case in platelets, which also exhibit increased GPVI signaling. This raises the possibility that a change in SFK activity in megakaryocytes could potentially underlie both the increase in platelet production and the reactivity to GPVI and integrin αIIbβ3 agonists observed in platelets. Despite the increase in SFK activity, megakaryocytes and platelets from LAIR-1 KO mice spread normally on collagen. We suspect this is because of the moderate phenotype and synergistic effects of multiple receptors and feedback pathways involved, masking any defect.
Previous work by Verbrugge et al 10 demonstrated that LAIR-1 mediates its inhibitory effect through its interaction 1 U/mL)-activated platelets were plated on a fibrinogen-coated surface. Ai, Representative differential interference contrast (DIC) and phalloidin-stained images of platelets. Aii, Surface area of individual platelets in DIC images was measured; n=3 to 5 mice/ genotype, 250 to 500 platelets/condition; mean±SEM; **P<0.01; scale bar: 5 µm. B, Increased αIIbβ3 signaling in LAIR-1 KO mice. Platelets from litter-matched wild-type (WT) and LAIR-1 KO mice were plated on 100 µg/mL fibrinogen-coated surfaces for 45 minutes at 37°C. Whole-cell lysates were prepared of nonadherent (NA) and fibrinogen (fib) adherent platelets. Bi, Equal amounts of total protein were resolved by SDS-PAGE and Western blotted with an anti-Src p-Tyr418, anti-Syk p-Tyr519/520, and anti-PLCγ2 p-Tyr1217. Membranes were subsequently stripped and reblotted with anti-Src, anti-Syk, and anti-PLCγ2 antibodies. Blots are representative of 4 independent experiments. Bii, Band intensities were quantified from 4 independent experiments (mean±SEM; *P<0.05). Increased glycoprotein VI (GPVI)-mediated signaling in platelets from leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) knockout (KO) mice. A, Whole-cell lysates of resting and 1 µg/mL collagen-related peptide (CRP)-stimulated platelets from litter-matched wild-type (WT) and LAIR-1 KO mice were Western blotted with anti-phosphotyrosine (p-Tyr) and anti-Src pTyr418 and membranes were stripped and reblotted with actin antibody. Ai, Representative blots and (Aii) densitometry quantification from n=3 independent experiments/ genotype (mean±SEM; *P<0.05, **P<0.01). B, Whole-cell lysates of resting and 1 µg/mL CRP-stimulated platelets from litter-matched WT and LAIR-1 KO mice were Western blotted with anti-Syk p-Tyr519/520 and anti-PLCγ2 p-Tyr1217 antibodies. Membranes were stripped and reblotted with antipan Syk and antipan PLCγ2 antibodies. Bi, Representative blots and (Bii) densitometry quantification from n=4 independent experiments/genotype (mean±SEM; *P<0.05). C, Anticoagulated blood was flowed through collagen-coated capillary tubes at 1000 s −1 for 4 minutes. Ci, Representative DIC images of fixed platelets on collagen fibrils are shown. Scale bar: 10 µm. Cii, Area covered by platelet thrombi was measured. Data presented are means (±SEM) of 3 independent experiments (**P<0.01). D, Laser injury-induced thrombus formation in vivo. Mice were injected with Dylight488-conjugated anti-GPIbβ antibody (0.1 µg/g body weight, ×488). Arterioles in cremaster muscles of recipients were subsequently injured by laser, and the accumulation of platelets (green) into the thrombi was assessed. Di, Representative composite brightfield and fluorescence images from ×488-labeled platelets after laser injury of arteriole are shown. Scale bar: 10 μm. Dii, Each curve represents the median integrated thrombus fluorescence intensity in arbitrary units (a.u.) for 23 to 73 thrombi induced in 4 to 12 mice/ genotype. See also Videos SI and SII in the online-only Data Supplement. E, Ferric chloride-induced thrombus formation in vivo. Mice were injected with DyLight488-conjugated anti-GPIbβ antibody (0.1 µg/g body weight, ×488). Exposed carotid arteries were injured with 10% ferric chloride for 3 minutes, and the accumulation of platelets (green) into the thrombi was assessed. Ei, Representative fluorescence images from ×488-labeled platelets after ferric chloride injury of carotid are shown. Scale bar: 200 μm. Eii, Each curve represents the median integrated fluorescence density in arbitrary units (a.u.) for 10 mice/genotype. Eiii, Area under the curve of the integrated fluorescence density is represented (mean±SEM; *P<0.05 using a Mann-Whitney U test). See also Videos SIII and SIV in the online-only Data Supplement.
with Shp1 and Shp2. LAIR-1 has also been shown to recruit C-terminal Src kinase to the plasma membrane, 10 which inhibits SFK activity by phosphorylating the C-terminal inhibitory tyrosine residue. Here, we report that LAIR-1 KO megakaryocytes exhibit increased basal SFK activity that is then transferred to platelets, rendering them hyper-responsive to collagen and fibrinogen, and represents a new paradigm of how platelet reactivity can be modulated. Although the mechanism underlying the increase in SFK activity in LAIR-1 KO megakaryocytes remains undefined, we hypothesize it is because of decreased compartmentalization of Shp1, Shp2, or C-terminal Src kinase at the plasma membrane, all of which have been implicated in regulating SFK activity either directly by modulating the relative level of phosphorylation of the C-terminal inhibitory and activation loop tyrosine residues or indirectly through regulation of adaptor proteins that unclamp and activate SFKs. 27 It should be noted that phosphorylation of the C-terminal inhibitory tyrosine residue of SFKs does not always correlate with SFK activity, whereas phosphorylation of the activation loop does. 28 Further work is needed to elucidate the exact mechanism underlying the increase in SFK activity in LAIR-1 KO megakaryocytes, and why it remains elevated in resting platelets.
The present study adds to the growing evidence that ITIM-containing receptors are critical regulators of platelet formation and function and sheds new light on the role of the collagen receptor LAIR-1 in regulating the basal activating state of megakaryocytes. LAIR-1 is, therefore, the third ITIM receptor that has been shown to regulate platelet formation. Mice deficient in PECAM-1 exhibit a significant decrease in platelet recovery after immune thrombocytopenia and increased platelet reactivity to collagen. 29 In contrast, mice lacking G6b-B have a pronounced thrombocytopenia and increased GPVI shedding. 2 This study establishes that deletion of LAIR-1 in megakaryocytes disrupts the homeostatic balance of megakaryocytes and platelets, shifting the balance to a prothrombotic state because of concomitant increases in platelet count and reactivity. Moreover, this study demonstrates that changes in the activation state of signaling proteins within the megakaryocytes lead to changes in platelets that are released into the circulation. Alteration in the megakaryocyte signaling proteins can, therefore, influence platelet functional responses. Although substantial progress has been made in understanding the mechanisms that regulate thrombopoiesis and platelet formation, we have yet to fully uncover what signaling pathways initiate and regulate these processes. A better understanding of these processes may result in therapies that stimulate immediate platelet production from existing megakaryocytes.
